15.10↑-0.64 (-4.07%)
12:00 AM,22nd Sep 2023BSE : 543500
NSE :
Sector : Others
ISIN Code : INE0JVD01011
Last Updated: Sep 22 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Evoq Remedies Ltd was originally incorporated as Salus Life Science and Research Private Limited at Ahmedabad Gujarat on February 24th 2010 under the provisions of Companies Act 1956 vide Certificate of Incorporation issued by Assistant Registrar of Companies Gujarat Dadra and Nagar Haveli. Subsequently name of the Company was changed to Evoq Remedies Private Limited on July 15th 2019 with Certificate of Incorporation pursuant to change of name issued by Registrar of Companies Ahmedabad. Consequent upon the conversion of Company into Public Limited Company the name was changed to Evoq Remedies Limited and fresh Certificate of Incorporation dated July 28th 2021 was issued by Registrar of Companies Ahmedabad. Although Company was formed in year 2010 it started operations in year 2018 onwards. The Company is a recognized trading house of Pharmaceuticals Raw Materials Excipients Bulk Drugs at affordable price catering to customers located in Ahmedabad. The company procures the pharmaceuticals Raw Materials products and chemicals from the customers who are having WHO-GMP approved production facilities in India and by focusing on its distribution skills. The Company is engaged in pharmaceutical business involving marketing trading and distribution of pharmaceutical formulation products such as antibiotic drugs antimalarial drugs antiallergic & anti cold drugs analgesic/ antipyretic & anti inflammatory drugs dermatology products cerebral activator drugs neurological drugs gastrointestinal drugs steroids gynecology drugs calcium multivitamins anti-oxidants and injections.The Company offer wide range of pharmaceuticals formulation products of which around 120 products are marketed by them under their own brand name the manufacturing of which is outsourced by them to third parties. Apart from pharmaceutical formulation products we also deal in trading of active pharmaceutical ingredients (API's).In areas like Pharmaceuticals Raw Materials Excipients Bulk Drugs etc. company specializes in offering quality products and affordable trading in Gujarat. In the healthcare segment the company being into trading business hence offers a wide basket of products. These pharmaceutical raw materials include both active pharmaceutical ingredients (APIs) and inactive ingredients or excipients.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 20 |
EPS - TTM (₹) [S] | 1.19 |
P/E Ratio (X) [S] | 0.83 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 18.23 |
P/B Ratio (₹) [S] | 0.83 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 15.10 16.20 |
Week Low/High | 14.81 16.00 |
Month Low/High | 13.78 16.00 |
Year Low/High | 10.91 18.00 |
All time Low/High | 10.91 25.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | % | % | -2.70 | -2.57% |
1 Month | 6.64% | % | 1.21 | 1.43% |
3 Month | -8.48% | % | 4.38 | 4.81% |
6 Month | 2.03% | % | 13.66 | 15.00% |
1 Year | -15.17% | % | 11.65 | 11.60% |
3 Year | % | % | 74.93 | 76.39% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
31-03-2023 | RAUNAK RAMUKA | BSE | SELL | 112000 | 12.16 |
11-04-2022 | KALPESH JAVERILAL OSWAL | BSE | SELL | 72000 | 17.40 |
30-03-2022 | KALPESH JAVERILAL OSWAL | BSE | BUY | 72000 | 24.38 |
30-03-2022 | SWASTIKA FINLEASE LIMITED | BSE | SELL | 88000 | 23.75 |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 73.53 |
Financial Institutions Banks | 0.00 |
Foreign Institutional Investors | 0.00 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 25.21 |
Others Non Institutional Investors | 1.26 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Director : Payal Bhumishth Patel
Director : Tarunkumar Gunvantlal Patel
Independent Director : Pranav Manoj Vajani
Independent Director : Digesh Deshaval
Managing Director : Dahyabhai Patel
Registered Office: F-12-A 1st Floor V R Complex, Nr.Sanathal Cross Road Santhal,Ahmedabad,Gujarat-382210 Ph: 91-79-4840 2525
Email:info@evoqremedies.com